Contributor Page
Marshall, Gerstein & Borun LLP
 
Email  |  Articles
Contact Details
Tel: +1 312 474 6300
Fax: +1 312 474 0448
233 South Wacker Drive
6300 Willis Tower
Chicago
IL 60606-6357
United States
By Jennifer Burnette
In Phigenix, Inc. v. ImmunoGen, Inc., the Federal Circuit dismissed, for lack of standing under Article III of the Constitution, a petitioner-appellant's appeal of a PTAB final written decision that refused to cancel claims challenged in an IPR.
By William K. Merkel
In IPR 2016-00039, Costco challenged claims 1, 12 and 14 of USPN 7,228,588 owned by Bosch and drawn to beam (non-yoked) windshield wipers with spoilers to keep the wipers in contact with...
By Katherine Neville
Three patents covering methods for administering the blockbuster multiple sclerosis drug Copaxone® (glatiramer acetate) were struck down by the PTAB in recent IPR decisions.
By Michael Weiner
A PTAB decision denying a patent owner's motion for discovery concerning privity illustrates what may be a carefully-structured business transaction that permitted a petitioner to avoid the effect of the one-year time-bar...
By Julianne Hartzell
35 U.S.C. § 284 provides that the a court "may increase damages awarded in a patent case by up to three times the amount found or assessed."